View Filing Data

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Oct. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	NU SKIN ENTERPRISES INC
Entity Central Index Key	0001021561
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		57,230,966
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 305,808	$ 288,415
Current investments	10,883	11,793
Accounts receivable	35,682	35,834
Inventories, net	260,464	338,491
Prepaid expenses and other	164,046	160,134
Total current assets	776,883	834,667
Property and equipment, net	459,644	464,783
Goodwill	112,446	112,446
Other intangible assets, net	68,862	75,062
Other assets	135,623	127,476
Total assets	1,553,458	1,614,434
Current liabilities:
Accounts payable	35,718	34,712
Accrued expenses	308,600	300,847
Current portion of long-term debt	66,743	82,770
Total current liabilities	411,061	418,329
Long-term debt	186,222	164,567
Other liabilities	95,657	89,100
Total liabilities	692,940	671,996
Commitments and contingencies (Note 9)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	415,026	414,394
Treasury stock, at cost - 31.7 million and 32.2 million shares	(959,504)	(862,608)
Accumulated other comprehensive loss	(73,000)	(51,521)
Retained earnings	1,477,905	1,442,082
Total stockholders' equity	860,518	942,438
Total liabilities and stockholders' equity	$ 1,553,458	$ 1,614,434

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2015	Dec. 31, 2014
Stockholders' equity:
Common stock, shares authorized (in shares)	500.0	500.0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	33.1	31.6

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 571,308	$ 638,800	$ 1,674,849	$ 1,959,888
Cost of sales	152,755	109,275	368,073	371,929
Gross profit	418,553	529,525	1,306,776	1,587,959
Operating expenses:
Selling expenses	240,260	263,203	713,714	859,879
General and administrative expenses	135,752	161,366	410,074	467,190
Total operating expenses	376,012	424,569	1,123,788	1,327,069
Operating income	42,541	104,956	182,988	260,890
Other income (expense), net	(14,428)	1,073	(29,454)	(37,554)
Income before provision for income taxes	28,113	106,029	153,534	223,336
Provision for income taxes	11,846	37,721	56,328	80,667
Net income	$ 16,267	$ 68,308	$ 97,206	$ 142,669
Net income per share (Note 2):
Basic (in dollars per share)	$ 0.28	$ 1.15	$ 1.66	$ 2.42
Diluted (in dollars per share)	$ 0.28	$ 1.12	$ 1.63	$ 2.34
Weighted-average common shares outstanding (000s):
Basic (in shares)	57,725	59,249	58,403	59,058
Diluted (in shares)	58,663	60,777	59,565	61,010

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net Income (Loss) Attributable to Parent	$ 16,267	$ 68,308	$ 97,206	$ 142,669
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustment	(9,629)	(3,392)	(20,355)	1,578
Net unrealized gains/(losses) on foreign currency cash flow hedges	(110)	1,239	199	656
Less: Reclassification adjustment for realized losses/gains in current earnings	(10)	(527)	(1,323)	(970)
Total	(9,749)	(2,680)	(21,479)	1,264
Comprehensive Income	$ 6,518	$ 65,628	$ 75,727	$ 143,933

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Other comprehensive income, net of tax:
Foreign currency translation adjustment, tax	$ 2,787	$ (2,311)	$ (3,036)	$ (2,367)
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	61	(683)	(109)	(361)
Reclassification adjustment for realized losses/(gains) in current earnings, tax	$ 5	$ 290	$ 729	$ 535

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 97,206	$ 142,669
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	52,101	38,933
Foreign currency (gains)/losses	24,953	47,570
Stock-based compensation	4,444	16,320
Deferred taxes	12,110	8,795
Changes in operating assets and liabilities:
Accounts receivable	(2,067)	27,094
Inventories, net	65,692	(37,107)
Prepaid expenses and other	(3,586)	(41,879)
Other assets	(18,387)	(17,721)
Accounts payable	2,252	(53,273)
Accrued expenses	15,455	(284,965)
Other liabilities	(8,209)	2,307
Net cash provided by operating activities	241,964	(151,257)
Cash flows from investing activities:
Purchases of property and equipment	(44,171)	(80,580)
Proceeds of investment sales	11,526	27,328
Purchases of investments	(11,526)	(17,522)
Net cash used in investing activities	(44,171)	(70,774)
Cash flows from financing activities:
Exercise of employee stock options	(1,107)	(3,146)
Payment of debt	(31,954)	(102,167)
Payment of cash dividends	(61,382)	(60,964)
Income tax benefit of options exercised	4,731	9,637
Proceeds from debt	36,217	115,220
Repurchases of shares of common stock	(104,058)	(25,002)
Net cash used in financing activities	(157,553)	(66,422)
Effect of exchange rate changes on cash	(22,847)	(41,756)
Net increase in cash and cash equivalents	17,393	(330,209)
Cash and cash equivalents, beginning of period	288,415	525,153
Cash and cash equivalents, end of period	$ 305,808	$ 194,944

THE COMPANY	9 Months Ended
THE COMPANY	Sep. 30, 2015
THE COMPANY [Abstract]
THE COMPANY	1. THE COMPANY Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last several years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC anti-aging brand. The Company reports revenue from five geographic regions: Greater China, which consists of Mainland China, Hong Kong, Macau and Taiwan; North Asia, which consists of Japan and South Korea; South Asia/Pacific, which consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; Americas, which consists of the United States, Canada and Latin America; and Europe, Middle East and Africa ("EMEA"), which consists of several markets in Europe as well as Israel, Russia, Ukraine and South Africa (the Company's subsidiaries operating in these countries in each region are collectively referred to as the "Subsidiaries"). The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of September 30, 2015, and for the three- and nine-month periods ended September 30, 2015 and 2014. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2014 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014. Certain prior-year amounts in the Consolidated Statements of Income, none of which are material to current or prior periods, have not been reclassified to conform with the current year presentation.

NET INCOME PER SHARE	9 Months Ended
NET INCOME PER SHARE	Sep. 30, 2015
NET INCOME PER SHARE [Abstract]
NET INCOME PER SHARE	2. NET INCOME PER SHARE Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended September 30, 2015 and 2014, stock options of 1.6 million and 2.8 million, respectively, and for the nine-month periods ended September 30, 2015 and 2014, stock options of 1.6 million and 2.1 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS PER SHARE	9 Months Ended
DIVIDENDS PER SHARE	Sep. 30, 2015
DIVIDENDS PER SHARE [Abstract]
DIVIDENDS PER SHARE	3. DIVIDENDS PER SHARE In January, April and August 2015, the Company's board of directors declared a quarterly cash dividend of $0.35 per share. These quarterly cash dividends of $20.7 million, $20.5 million and $20.2 million were paid on March 18, 2015, June 10, 2015 and September 16, 2015 to stockholders of record on February 27, 2015, May 22, 2015 and August 28, 2015. In October 2015, the Company's board of directors declared a quarterly cash dividend of $0.35 per share to be paid on December 9, 2015 to stockholders of record on November 20, 2015.

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS	Sep. 30, 2015
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	4. DERIVATIVE FINANCIAL INSTRUMENTS The Company held mark-to-market forward contracts designated as foreign currency cash flow hedges with notional amounts of 2.0 billion Japanese yen and 15.0 million euros ($16.7 million and $16.8 million, respectively) as of September 30, 2015 and 800 million Japanese yen and 7.0 million euros ($7.3 million and $8.8 million, respectively) as of September 30, 2014, to hedge forecasted foreign-currency-denominated intercompany transactions. The contracts held at September 30, 2015 have maturities through December 2016 and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive loss will be recognized in current earnings over the next 15 months. The pre-tax net gains on foreign currency cash flow hedges reclassified from accumulated other comprehensive loss to the income statement were none and $0.8 million, respectively, for the three-month periods ended September 30, 2015 and 2014 and $2.1 million and $1.5 million, respectively, for the nine-month periods ended September 30, 2015 and 2014. The corresponding tax effects of these transactions were recorded in provision for income tax expense. As of September 30, 2015 and December 31, 2014, there were $0.1 million of unrealized losses and $1.1 million of unrealized gains included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $72.9 million and $52.6 million as of September 30, 2015 and December 31, 2014, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

REPURCHASES OF COMMON STOCK	9 Months Ended
REPURCHASES OF COMMON STOCK	Sep. 30, 2015
REPURCHASES OF COMMON STOCK [Abstract]
REPURCHASES OF COMMON STOCK	5. REPURCHASES OF COMMON STOCK During the three-month period ended September 30, 2015, the Company repurchased 0.6 million shares of its Class A common stock under its open market stock repurchase plan for $28.2 million. The Company did not repurchase any shares of its Class A common stock under its open market stock repurchase plan during the three-month period ended September 30, 2014. During the nine-month periods ended September 30, 2015 and 2014, the Company repurchased 2.1 million and 0.3 million shares of its Class A common stock under its open market repurchase plan for $104.1 million and $25.0 million, respectively. As of September 30, 2015, $244.8 million was available for repurchases under the open market stock repurchase plan. In October 2015, our board terminated the open market stock repurchase plan and approved a new repurchase plan with an initial authorization amount of $500.0 million.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

+ Details

SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2015

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

6. SEGMENT INFORMATION

The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, independent direct sellers and independent marketers to distribute its products. Independent direct sellers can sell away from the Company's stores where the Company has obtained a direct selling license to do so. Independent marketers are licensed business owners who are authorized to sell the Company's products either at their own approved premises or through the Company's stores. Selling expenses are the Company's largest expense, comprised of sales compensation and incentives paid to its sales force. The Company manages its business primarily by managing its sales force. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in five geographic regions: Greater China, North Asia, South Asia/Pacific, Americas and EMEA.

NU SKIN ENTERPRISES, INC.

Notes to Consolidated Financial Statements

Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Greater China	$	188,669	$	226,744	$	576,172	$	735,542
North Asia		167,748		205,488		512,757		596,944
South Asia/Pacific		108,857		88,915		247,697		241,762
Americas		70,775		76,737		234,115		246,557
EMEA		35,259		40,916		104,108		139,083
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Nu Skin	$	324,115	$	392,513	$	1,018,317	$	1,186,592
Pharmanex		245,569		244,690		652,345		768,178
Other		1,624		1,597		4,187		5,118
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Mainland China	$	138,050	$	152,983	$	421,498	$	518,995
South Korea		104,012		127,094		321,812		359,891
Japan		63,736		78,394		190,945		237,053
United States		52,720		54,241		170,288		170,119

Long-lived assets:	September 30, 2015		December 31, 2014

Mainland China	$	112,915	$	103,445
South Korea		48,977		46,626
Japan		14,404		13,768
United States		272,034		287,103

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

DEFERRED TAX ASSETS AND LIABILITIES	9 Months Ended
DEFERRED TAX ASSETS AND LIABILITIES	Sep. 30, 2015
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]
DEFERRED TAX ASSETS AND LIABILITIES	7. DEFERRED TAX ASSETS AND LIABILITIES The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. As of September 30, 2015 and December 31, 2014, the Company had net deferred tax assets of $27.1 million and $40.0 million, respectively. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal and state income taxes applicable to the earnings. For all foreign earnings, the Company accrues the applicable foreign income taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no federal or state income taxes in the U.S. have been provided, aggregate to $50.0 million as of December 31, 2014 and September 30, 2015. The company anticipates indefinitely reinvesting an additional $20.0 million for the year ended December 31, 2015. If the amount designated as indefinitely reinvested as of December 31, 2014 was repatriated to the United States, the amount of incremental taxes would be approximately $5.3 million.

UNCERTAIN TAX POSITIONS	9 Months Ended
UNCERTAIN TAX POSITIONS	Sep. 30, 2015
UNCERTAIN TAX POSITIONS [Abstract]
UNCERTAIN TAX POSITIONS	8. UNCERTAIN TAX POSITIONS The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company has filed U.S. federal tax returns for all years through and including 2014, and is no longer subject to tax examinations from the United States Internal Revenue Service (the "IRS") for any of these years except for 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2011. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2016 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is no longer subject to income tax examinations for years before 2009. However, statutes in certain countries may be as long as ten years for transfer pricing related issues. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may increase within the next 12 months by a range of approximately $0.1 million to $1.0 million.

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	9. COMMITMENTS AND CONTINGENCIES The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance in all material respects with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position or results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation and proceedings involving various matters. Except as noted below, in the opinion of the Company's management, based upon advice of its counsel handling such litigation and proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results. The Company is currently involved in a dispute related to customs assessments by Yokohama Customs on several of the Company's products for the period of October 2006 through September 2009 in connection with post-importation audits, as well as the disputed portion of the Company's import duties from October 2009 to the present, which the Company has or will hold in bond or pay under protest (the Company was previously required to post a bond or make a deposit to secure any additional duties that may have been due and payable on current imports, but it is no longer required to do so). Additional assessments related to any prior period are barred by applicable statutes of limitations. The aggregate amount of these assessments and disputed duties was approximately 4.4 billion Japanese yen as of September 30, 2015 (approximately $37.0 million), net of recovery of consumption taxes. The issue in this case is whether a United States entity utilizing a commissionaire agent in Japan to import its products can use the manufacturer's invoice pursuant to the transaction value method under the World Trade Organization Customs Valuation Agreement or whether it must use one of the alternative valuation methods provided in that agreement, and, if an alternative method must be used, what the allowable deductions would be in determining the proper valuation. Following the Company's review of the assessments and after consulting with the Company's legal and customs advisors, the Company believes that use of the manufacturer's invoice is the appropriate valuation method and that the additional assessments are improper and are not supported by applicable customs laws because they are based on an alternative valuation method. Because the Company believes that the assessment of higher duties by the customs authorities is an improper application of the regulations, the Company is currently expensing the portion of the duties the Company believes is supported under applicable customs law, and recording the additional deposit or payment as a receivable within long-term assets on its consolidated financial statements. The Company filed letters of protest with the applicable Customs authorities, which were rejected. The Company then appealed the matter to the Ministry of Finance in Japan. In the second quarter of 2011, the Ministry of Finance in Japan denied the Company's administrative appeal. The Company disagrees with the Ministry of Finance's administrative decision. The Company is now pursuing the matter in Tokyo District Court, which is not required to give deference to the decision made by the Ministry of Finance and which the Company believes will provide a more independent determination of the matter. In June 2015, the Tokyo District Court closed the proceedings, and we currently anticipate a decision on the matter sometime this year. If the Company is unsuccessful in recovering the amounts assessed and paid, the Company will record a non-cash expense for the full amount of the disputed assessments. The Company anticipates that additional disputed duties will be limited going forward as the Company purchases a majority of the affected products in Japan from a Japanese company that purchases and imports the products from the manufacturers. The Company is also currently being sued in a purported class action lawsuit and derivative claim relating to negative media and regulatory scrutiny regarding the Company's business in Mainland China and the associated decline in the Company's stock price. Beginning in January 2014, six purported class action complaints were filed in the United States District Court for the District of Utah. On May 1, 2014, the court consolidated the various purported class actions, appointed State-Boston Retirement System as lead plaintiff in the consolidated action and appointed the law firm Labaton Sucharow as lead counsel for the purported class in the consolidated action. On June 30, 2014, a consolidated class action complaint was filed. On February 26, 2015, the court denied the Company's motion to dismiss the case. The consolidated class action complaint purports to assert claims on behalf of certain of the Company's stockholders under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder against Nu Skin Enterprises, Ritch N. Wood, and M. Truman Hunt and to assert claims under Section 20(a) of the Securities Exchange Act of 1934 against Messrs. Wood and Hunt. The consolidated class action complaint alleges that, inter alia, the Company made materially false and misleading statements regarding its sales operations in and financial results derived from Mainland China, including purportedly operating a pyramid scheme based on illegal multi-level marketing activities. The Company believes that the claims asserted in the consolidated class action complaint are without merit and intends to vigorously defend itself. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements In addition, beginning in February 2014, five purported shareholder derivative complaints were filed in the United States District Court for the District of Utah. On May 1, 2014, the court issued an order consolidating the derivative actions, appointing plaintiffs Amos. C. Acoff and Analisa Suderov as co-lead plaintiffs in the consolidated action, and appointing the law firms Bernstein Litowitz Berger & Grossmann LLP and The Weiser Law Firm, P.C. as co-lead counsel for the plaintiffs in the consolidated action. On July 25, 2014, a consolidated derivative complaint was filed. On July 17, 2015, the court stayed the derivative action pending a resolution in the securities class action lawsuit and denied the Company's motion to dismiss without prejudice to renewing the motion when the stay is lifted. The consolidated derivative complaint purports to assert claims on behalf of Nu Skin Enterprises, Inc. for, inter alia, breach of fiduciary duties for disseminating false and misleading information, failing to maintain adequate internal controls, unjust enrichment, abuse of control, and gross mismanagement against M. Truman Hunt, Ritch N. Wood, Steven J. Lund, Nevin N. Andersen, Neil H. Offen, Daniel W. Campbell, Andrew W. Lipman, Patricia A. Negrón, Thomas R. Pisano, and nominally against Nu Skin Enterprises, Inc. The consolidated derivative complaint also purports to assert claims on behalf of Nu Skin Enterprises, Inc. for breach of fiduciary duty for insider selling and misappropriation of information against Messrs. Wood, Lund and Campbell. The consolidated derivative complaint alleges that, inter alia, the defendants allowed materially false and misleading statements to be made regarding their sales operations in and financial results derived from Mainland China, including purportedly operating a pyramid scheme based on illegal multi-level marketing activities, and that certain defendants sold common stock on the basis of material, adverse non-public information. The purported class action lawsuit and derivative claim, or others filed alleging similar facts, could result in monetary or other penalties that may materially affect the Company's operating results and financial condition. At this stage of the proceedings, the Company is unable to make an estimate of the potential loss, if any, arising from these matters.

DEBT

9 Months Ended

Sep. 30, 2015

DEBT [Abstract]

DEBT

10. DEBT

The following table summarizes the Company's debt facilities as of September 30, 2015. The Company's book value for both the individual and consolidated debt included in the table approximates fair value. The estimated fair value of its debt is based on interest rates available for debt with similar terms and remaining maturities. The Company has classified these instruments as Level 2 in the fair value hierarchy.

Facility or Arrangement	Original Principal Amount	Balance as of December 31, 2014	Balance as of September 30, 2015⁽¹⁾⁽²⁾	Interest Rate	Repayment terms

Credit Agreement term loan facility:
U.S. dollar denominated:	$127.5 million	$125.9 million	$121.1 million	Variable 30 day: 2.447%	One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Japanese yen denominated:	6.6 billion yen	6.5 billion yen ($54.4 million as of December 31, 2014)	6.3 billion yen ($52.3 million as of September 30, 2015)	Variable 30 day: 2.305%	One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility:
		$72.5 million	$47.5 million	Variable 30 day: 2.447%	Revolving line of credit expires October 2019.

Korea subsidiary loan:
	$20.0 million	─	$20.0 million	1.12%	One half of the principal amount payable on March 17, 2017 and the remainder payable on March 16, 2018.

Japan subsidiary loan:
	2.0 billion yen	─	2.0 billion yen ($16.7 million as of September 30, 2015)	0.66%	Payable in semi-annual installments over three years beginning January 31, 2016.

(1)

As of September 30, 2015, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $57.1 million of the balance of its U.S. dollar-denominated debt under the Credit Agreement term loan facility, $4.1 million of the balance of its Japanese yen-denominated debt under the Credit Agreement term loan facility and $5.5 million of the Japan subsidiary loan. The Company has classified the amount borrowed under the Credit Agreement revolving credit facility as short term because it is the Company's intention to use this line of credit to borrow and pay back funds over short periods of time.

(2)	The carrying value of the debt reflects the amounts stated in the above table less debt financing costs of $4.6 million, which are not reflected in this table.

ACCOUNTING PRONOUNCEMENTS	9 Months Ended
ACCOUNTING PRONOUNCEMENTS	Sep. 30, 2015
ACCOUNTING PRONOUNCEMENTS [Abstract]
ACCOUNTING PRONOUNCEMENTS	11. ACCOUNTING PRONOUNCEMENTS In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the threshold for a disposal to qualify as a discontinued operation. To be considered a discontinued operation, a disposal now must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. This ASU also requires new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This update will be applied prospectively and was effective for annual periods, and interim periods within those years, beginning after December 15, 2014. The adoption of this standard did not have a material impact on the Company's financial statements. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU is effective for annual periods beginning after December 15, 2017 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is evaluating the potential impact of this adoption on its consolidated financial statements. In June 2014, the FASB issued ASU No. 2014-12, Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). This ASU clarifies that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. This ASU is effective for annual periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted. This ASU may be applied either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The Company is evaluating the potential impact of this adoption on its consolidated financial statements. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements — Going Concern (Subtopic 205-40). The purpose of this ASU is to incorporate into U.S. GAAP management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern within one year after the date that the financial statements are issued, and to provide related footnote disclosures. This update is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, which requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. ASU 2015-03 will not change the amortization of debt issuance costs, which will continue to follow the existing accounting guidance. In August 2015, the FASB issued ASU 2015-15, Interest – Imputations of Interest, due to the absence of guidance within update 2015-03 for debt issuance costs related to line-of-credit arrangements. ASU 2015-15 states that the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. ASU 2015-03 and ASU 2015-15 will be effective for interim and annual reporting periods beginning after December 15, 2015. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory - Inventory (Topic 330). This ASU changes the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. Net realizable value is defined as the "estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation." ASU 2015-11 eliminates the guidance that entities consider replacement cost or net realizable value less an approximately normal profit margin in the subsequent measurement of inventory when cost is determined on a first-in, first-out or average cost basis. The provisions of ASU 2015-11 are effective for public entities with fiscal years beginning after December 15, 2016. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	9 Months Ended
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	Sep. 30, 2015
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING [Abstract]
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	12. VENEZUELA HIGHLY INFLATIONARY ACCOUNTING The Company commenced operations in Venezuela in 2007, where it markets a variety of personal care and nutritional products. Total assets in Venezuela as of September 30, 2015 and December 31, 2014 are $8.2 million and $14.6 million, of which $3.2 million and $8.2 million are monetary assets in each year respectively. The Venezuela subsidiary also had a $32.8 million and $34.8 million intercompany balance to its parent company as of September 30, 2015 and December 31, 2014, with respect to charges for inventory, commissions, license fees and service fees. The Company imports all of its products into Venezuela from the United States. Venezuela represents a very small portion of the Company's overall business with sales during 2012, 2013 and 2014 representing approximately 0.7%, 1.1% and 1.0% of the Company's overall revenue, respectively. Since November of 2009, Venezuela has been considered a highly inflationary economy. A country is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity's parent company (which for our Venezuela subsidiary is the U.S. dollar), and transactions denominated in the local currency are remeasured to the functional currency. The remeasurement of bolivars into U.S. dollars creates foreign currency transaction gains or losses, which the Company includes in its consolidated statement of income. The Venezuela subsidiary did not transition to highly inflationary status until the first quarter of 2014. As a result, the Company continued to account for the Venezuela subsidiary as a bolivar functional currency entity, rather than a U.S. dollar functional currency entity. In the first quarter of 2014, the Company began to account for this subsidiary as highly inflationary, and therefore changed the functional currency of the entity to the U.S. dollar. The consolidated statement of income for the quarter ended March 31, 2014, included an out-of-period adjustment of $6.3 million to correct this error as it was not deemed to be material to the current- or prior-period financial statements. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements The current operating environment in Venezuela continues to be challenging, with high inflation in the country, government restrictions on foreign exchange and pricing controls, and the possibility of the government announcing further devaluations to its currency. Currency restrictions enacted by the Venezuelan government have impacted the ability of the Company to exchange foreign currency at the official rate to pay for imported products, license fees, commissions and other service fees. The Company has been unsuccessful in obtaining U.S. dollars at the official exchange rates and under alternative exchange mechanisms described below. As a result, these foreign exchange controls in Venezuela have limited the Company's ability to repatriate earnings and settle the Company's intercompany obligations, which has resulted in the accumulation of bolivar-denominated cash and cash equivalents in Venezuela. During the first quarter of 2014, two new foreign exchange mechanisms ("SICAD I" and "SICAD II") became available in Venezuela. As of March 31, 2014, the Company determined it would be most appropriate for it to utilize the SICAD I rate, which was approximately 10.7 bolivars per U.S. dollar. As a result of the adoption of this rate during the period ended March 31, 2014, the Company recorded a $14.7 million charge in Other Income (Expense) to reflect foreign currency transaction losses on its net monetary assets denominated in bolivar, which was reflected in the quarter ended March 31, 2014. As of June 30, 2014, the Company determined that it would be most appropriate for it to utilize the SICAD II rate, which was approximately 50 bolivars per U.S. dollar, as the Company had not been successful in getting approval under SICAD I and believed the SICAD II rate better reflects the rate at which the Company will be able to convert bolivars to U.S. dollars. As a result of the adoption of this rate during the three months ended June 30, 2014, the Company recorded an additional $25.3 million charge in Other Income (Expense) to reflect additional foreign currency translation losses on its net monetary assets denominated in bolivar, which was reflected in the year ended December 31, 2014. In the first quarter of 2015, Venezuela announced that it merged its SICAD I and SICAD II mechanisms into a single mechanism ("SICAD"), and it announced a new foreign exchange mechanism ("SIMADI"), which utilizes a variable exchange rate that was approximately 193 bolivars per U.S. dollar as of March 31, 2015. During the first quarter, the Company determined it would be most appropriate to utilize the SIMADI rate. The remeasurement of the Company's net monetary assets and liabilities denominated in bolivars as a result of this change resulted in a foreign currency exchange loss of $10.2 million during the first quarter of 2015.

- Definition

The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.

+ References + Details

LEASE AND FINANCING OBLIGATIONS	9 Months Ended
LEASE AND FINANCING OBLIGATIONS	Sep. 30, 2015
LEASE AND FINANCING OBLIGATIONS [Abstract]
LEASE AND FINANCING OBLIGATIONS	13. LEASE AND FINANCING OBLIGATIONS In 2014, the Company's subsidiary in South Korea entered into a lease agreement with a third-party landlord for office buildings. In April 2015, the Company and the landlord entered into a new lease agreement on terms generally consistent with the 2014 lease. As part of the lease, the landlord agreed to renovate an existing building (the "Existing Building") and construct a new building (the "New Building") adjacent to the Existing Building. The Company accounts for its lease of the Existing Building as an operating lease. As an inducement to enter into the lease, the landlord agreed to make certain improvements on behalf of the Company to the Existing Building. The improvements have been accounted for by the Company as a tenant incentive. NU SKIN ENTERPRISES, INC. Notes to Consolidated Financial Statements The Company has concluded that it is the deemed owner (for accounting purposes only) of the New Building during the construction period under build-to-suit lease accounting. At September 30, 2015, the Company had recognized $20.1 million as the value of the New Building offset by accumulated depreciation of $0.2 million. The Company also booked a corresponding financing obligation in the amount of $10.7 million, net of a $9.3 million deposit paid directly to the landlord, as part of Other liabilities in its consolidated balance sheets. The Company does not expect to recognize any additional project costs associated with the construction of the New Building or any additional financing obligation. The Company had also recognized a $5.9 million tenant incentive asset and deferred tenant incentive liability associated with the Existing Building at September 30, 2015.

ADJUSTMENT TO INVENTORY	9 Months Ended
ADJUSTMENT TO INVENTORY	Sep. 30, 2015
ADJUSTMENT TO INVENTORY [Abstract]
ADJUSTMENT TO INVENTORY	14. ADJUSTMENTS TO INVENTORY During the second quarter of 2014, the Company made a determination to adjust its inventory carrying value. Heightened media and regulatory scrutiny in Mainland China in the first part of 2014, and the voluntary actions the Company took in response to such scrutiny, had a negative impact on the size of the Company's limited-time offer in June 2014, which significantly reduced its expectations for plans to sell our ageLOC TR90 weight management and body shaping system in a limited-time offer later in 2014 or the beginning of 2015. This resulted in a $50.0 million write-down of estimated surplus inventory primarily in Mainland China. During the third quarter of 2015, the Company made a determination to further adjust its inventory carrying value. A sequential decrease in revenue for the third quarter of 2015, together with a decision not to continue discounted product promotions in the Greater China region to focus Sales Leaders on the launch of our ageLOC Me personalized skin care system, reduced the Company's expectations for future product sales, resulting in estimated surplus inventory. This resulted in a $37.9 million write-down of the Company's inventory balance in Greater China. Total adjustments to the Company's inventory carrying value as of September 30, 2015 and December 31, 2014 were $65.0 million and $56.0 million, respectively.

ADDITIONAL QUARTERLY DISCLOSURES

9 Months Ended

Sep. 30, 2015

ADDITIONAL QUARTERLY DISCLOSURES [Abstract]

ADDITIONAL QUARTERLY DISCLOSURES

15. ADDITIONAL QUARTERLY DISCLOSURES

Inventory

Inventories consist of the following (U.S. dollars in thousands):

	September 30, 2015		December 31, 2014

Raw materials	$	132,808	$	101,479
Finished goods		127,656		237,012
	$	260,464	$	338,491

NU SKIN ENTERPRISES, INC.

Notes to Consolidated Financial Statements

Fair Value

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at September 30, 2015
	Level 1		Level 2			Level 3		Total

Financial assets (liabilities):
Cash equivalents and current investments	$	53,043	$ ─			$ ─		$	53,043
Forward contracts	─			(83	)	─			(83	)
Life insurance contracts	─		─				26,713		26,713
Total	$	53,043	$	(83	)	$	26,713	$	79,673

	Fair Value at December 31, 2014
	Level 1		Level 2		Level 3		Total

Financial assets (liabilities):
Cash equivalents and current investments	$	86,574	$ ─		$ ─		$	86,574
Forward contracts	─			1,661	─			1,661
Life insurance contracts	─		─			26,280		26,280
Total	$	86,574	$	1,661	$	26,280	$	114,515

The following table provides a summary of changes in fair value of the Company's Level 3 marketable securities (U.S. dollars in thousands):

Life Insurance Contracts

Beginning balance at January 1, 2015	$	26,280
Actual return on plan assets:
Relating to assets still held at the reporting date		(1,475	)
Purchases and issuances		2,282
Sales and settlements		(374	)
Transfers into Level 3	─
Ending balance at September 30, 2015	$	26,713

SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2015

SEGMENT INFORMATION [Abstract]

Revenue by Region

Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Greater China	$	188,669	$	226,744	$	576,172	$	735,542
North Asia		167,748		205,488		512,757		596,944
South Asia/Pacific		108,857		88,915		247,697		241,762
Americas		70,775		76,737		234,115		246,557
EMEA		35,259		40,916		104,108		139,083
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Revenue by Product Lines

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Nu Skin	$	324,115	$	392,513	$	1,018,317	$	1,186,592
Pharmanex		245,569		244,690		652,345		768,178
Other		1,624		1,597		4,187		5,118
Totals	$	571,308	$	638,800	$	1,674,849	$	1,959,888

Revenue and Long-Lived Assets by Significant Geographic Areas

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
Revenue:	2015		2014		2015		2014

Mainland China	$	138,050	$	152,983	$	421,498	$	518,995
South Korea		104,012		127,094		321,812		359,891
Japan		63,736		78,394		190,945		237,053
United States		52,720		54,241		170,288		170,119

Long-lived assets:	September 30, 2015		December 31, 2014

Mainland China	$	112,915	$	103,445
South Korea		48,977		46,626
Japan		14,404		13,768
United States		272,034		287,103

DEBT (Tables)

9 Months Ended

Sep. 30, 2015

DEBT [Abstract]

Debt Facilities

Facility or Arrangement	Original Principal Amount	Balance as of December 31, 2014	Balance as of September 30, 2015⁽¹⁾⁽²⁾	Interest Rate	Repayment terms

Credit Agreement term loan facility:
U.S. dollar denominated:	$127.5 million	$125.9 million	$121.1 million	Variable 30 day: 2.447%	One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Japanese yen denominated:	6.6 billion yen	6.5 billion yen ($54.4 million as of December 31, 2014)	6.3 billion yen ($52.3 million as of September 30, 2015)	Variable 30 day: 2.305%	One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Credit Agreement revolving credit facility:
		$72.5 million	$47.5 million	Variable 30 day: 2.447%	Revolving line of credit expires October 2019.

Korea subsidiary loan:
	$20.0 million	─	$20.0 million	1.12%	One half of the principal amount payable on March 17, 2017 and the remainder payable on March 16, 2018.

Japan subsidiary loan:
	2.0 billion yen	─	2.0 billion yen ($16.7 million as of September 30, 2015)	0.66%	Payable in semi-annual installments over three years beginning January 31, 2016.

(1)

(2)	The carrying value of the debt reflects the amounts stated in the above table less debt financing costs of $4.6 million, which are not reflected in this table.

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

ADDITIONAL QUARTERLY DISCLOSURES (Tables)

9 Months Ended

Sep. 30, 2015

ADDITIONAL QUARTERLY DISCLOSURES [Abstract]

Inventories

Inventories consist of the following (U.S. dollars in thousands):

	September 30, 2015		December 31, 2014

Raw materials	$	132,808	$	101,479
Finished goods		127,656		237,012
	$	260,464	$	338,491

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):

	Fair Value at September 30, 2015
	Level 1		Level 2			Level 3		Total

Financial assets (liabilities):
Cash equivalents and current investments	$	53,043	$ ─			$ ─		$	53,043
Forward contracts	─			(83	)	─			(83	)
Life insurance contracts	─		─				26,713		26,713
Total	$	53,043	$	(83	)	$	26,713	$	79,673

	Fair Value at December 31, 2014
	Level 1		Level 2		Level 3		Total

Financial assets (liabilities):
Cash equivalents and current investments	$	86,574	$ ─		$ ─		$	86,574
Forward contracts	─			1,661	─			1,661
Life insurance contracts	─		─			26,280		26,280
Total	$	86,574	$	1,661	$	26,280	$	114,515

Changes in Fair Value of Marketable Securities

The following table provides a summary of changes in fair value of the Company's Level 3 marketable securities (U.S. dollars in thousands):

Life Insurance Contracts

Beginning balance at January 1, 2015	$	26,280
Actual return on plan assets:
Relating to assets still held at the reporting date		(1,475	)
Purchases and issuances		2,282
Sales and settlements		(374	)
Transfers into Level 3	─
Ending balance at September 30, 2015	$	26,713

THE COMPANY (Details)	9 Months Ended
THE COMPANY (Details)	Sep. 30, 2015 Region
THE COMPANY [Abstract]
Number of geographic regions	5

NET INCOME PER SHARE (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
NET INCOME PER SHARE (Details) - shares shares in Millions	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
NET INCOME PER SHARE [Abstract]
Other shares excluded from the calculation of diluted earnings per share (in shares)	1.6	2.8	1.6	2.1

DIVIDENDS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended		9 Months Ended
	Sep. 16, 2015	Jun. 10, 2015	Mar. 18, 2015	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014
Dividends per Share [Abstract]
Date declared				2015-01			2015-01
Payment of cash dividends					$ 20,700	$ 61,382	$ 60,964
Date paid						Mar. 18, 2015
Date of record						Feb. 27, 2015
Dividend Declared 2015-Q1 [Member]
Dividends per Share [Abstract]
Date declared				2015-04			2015-04
Cash dividend declared (in dollars per share)			$ 0.350
Payment of cash dividends			$ 20,500
Date paid						Jun. 10, 2015
Date of record						May 22, 2015
Dividend Declared 2015-Q2 [Member]
Dividends per Share [Abstract]
Date declared						2015-09
Cash dividend declared (in dollars per share)		$ 0.350
Payment of cash dividends		$ 20,200
Date paid						Sep. 16, 2015
Date of record						Aug. 28, 2015
Dividend Declared 2015-Q3 [Member]
Dividends per Share [Abstract]
Date declared						2015-10
Cash dividend declared (in dollars per share)	$ 0.350			$ 0.350
Date paid						Oct. 09, 2015
Date of record						Nov. 20, 2015

DERIVATIVE FINANCIAL INSTRUMENTS (Details) $ in Thousands, € in Millions, ¥ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 EUR (€)	Sep. 30, 2015 JPY (¥)	Dec. 31, 2014 USD ($)	Sep. 30, 2014 EUR (€)	Sep. 30, 2014 JPY (¥)	Dec. 31, 2013 USD ($)	Sep. 30, 2013 USD ($)
Derivative Financial Instruments [Abstract]
Revenue	$ 571,308	$ 638,800	$ 1,674,849	$ 1,959,888
Derivative Financial Instruments [Abstract]
Accumulated other comprehensive income (loss)	(73,000)		(73,000)				$ (51,521)
Deferred tax assets	27,100		27,100							$ 40,000
Accumulated Unrealized Gains (Losses) on Foreign Currency Cash Flow Hedges [Member]
Derivative Financial Instruments [Abstract]
Accumulated other comprehensive income (loss)	100		100				1,100
Accumulated Unrealized Gains (Losses) on Foreign Currency Cash Flow Hedges [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Derivative Financial Instruments [Abstract]
Revenue	0	800	2,100	1,500
Accumulated Translation Adjustment [Member]
Derivative Financial Instruments [Abstract]
Accumulated other comprehensive income (loss)	(72,900)		(72,900)				$ (52,600)
Forward Contracts [Member] \| Cash Flow Hedges [Member] \| Japanese Yen [Member]
Derivative Financial Instruments [Abstract]
Notional amount	16,700	$ 7,300	16,700	$ 7,300		¥ 2,000.0			¥ 800.0
Forward Contracts [Member] \| Cash Flow Hedges [Member] \| Euros [Member]
Derivative Financial Instruments [Abstract]
Notional amount	$ 16,800		$ 16,800		€ 15.0			€ 7.0			$ 8,800

REPURCHASES OF COMMON STOCK (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Oct. 30, 2015
Repurchases of Common Stock [Abstract]
Common stock repurchased (in shares)	0.6	0.0	2.1	0.3
Common stock repurchased	$ 28,200	$ 0	$ 104,100	$ 25,000
Available for repurchase under the repurchase program	$ 244,800		$ 244,800		$ 500,000

SEGMENT INFORMATION (Details) $ in Thousands	3 Months Ended		9 Months Ended
SEGMENT INFORMATION (Details) $ in Thousands	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) Region ProductLine	Sep. 30, 2014 USD ($)	Dec. 31, 2014 USD ($)
SEGMENT INFORMATION [Abstract]
Number of geographic regions \| Region			5
Number of product lines \| ProductLine			3
Segment Information [Abstract]
Revenue	$ 571,308	$ 638,800	$ 1,674,849	$ 1,959,888
Nu Skin [Member]
Segment Information [Abstract]
Revenue	324,115	392,513	1,018,317	1,186,592
Pharmanex [Member]
Segment Information [Abstract]
Revenue	245,569	244,690	652,345	768,178
Other Product Lines [Member]
Segment Information [Abstract]
Revenue	1,624	1,597	4,187	5,118
Greater China [Member]
Segment Information [Abstract]
Revenue	188,669	226,744	576,172	735,542
North Asia [Member]
Segment Information [Abstract]
Revenue	167,748	205,488	512,757	596,944
Americas [Member]
Segment Information [Abstract]
Revenue	70,775	76,737	234,115	246,557
South Asia/Pacific [Member]
Segment Information [Abstract]
Revenue	108,857	88,915	247,697	241,762
EMEA [Member]
Segment Information [Abstract]
Revenue	35,259	40,916	104,108	139,083
Japan [Member]
Segment Information [Abstract]
Revenue	63,736	78,394	190,945	237,053
Long-lived assets	14,404		14,404		$ 13,768
Mainland China [Member]
Segment Information [Abstract]
Revenue	138,050	152,983	421,498	518,995
Long-lived assets	112,915		112,915		103,445
South Korea [Member]
Segment Information [Abstract]
Revenue	104,012	127,094	321,812	359,891
Long-lived assets	48,977		48,977		46,626
United States [Member]
Segment Information [Abstract]
Revenue	52,720	$ 54,241	170,288	$ 170,119
Long-lived assets	$ 272,034		$ 272,034		$ 287,103

DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]
Net deferred tax assets	$ 27.1		$ 40.0
Undistributed foreign earnings indefinitely reinvested	50.0	$ 50.0
Additional undistributed foreign earnings expected to be indefinitely reinvested in 2015	20.0
Incremental taxes on indefinitely reinvested foreign earnings	$ 5.3

UNCERTAIN TAX POSITIONS (Details) - Operations in Multiple Foreign and Domestic Jurisdictions and Expiration of Various Statutes of Limitation [Member] $ in Millions	Sep. 30, 2015 USD ($)
Minimum [Member]
Uncertain Tax Positions [Abstract]
Increase in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months	$ 0.1
Maximum [Member]
Uncertain Tax Positions [Abstract]
Increase in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months	$ 1.0

COMMITMENTS AND CONTINGENCIES (Details) - Sep. 30, 2015 $ in Millions, ¥ in Billions	USD ($)	JPY (¥)
Dispute Related to Customs Assessments by Yokohama Customs [Member]
Commitments and Contingencies [Abstract]
Estimated assessments and disputed duties	$ 37.0	¥ 4.4

DEBT (Details)
$ in Thousands, ¥ in Billions

9 Months Ended

Sep. 30, 2015

USD ($)

Sep. 30, 2015

JPY (¥)

Jul. 31, 2015

USD ($)

Jul. 31, 2015

JPY (¥)

Jun. 30, 2015

USD ($)

Jun. 30, 2015

JPY (¥)

Dec. 31, 2014

USD ($)

Debt Facilities [Abstract]

Current portion of long-term debt

$ 66,743

$ 82,770

Debt discount

4,600

Credit Agreement Term Loan Facility U.S. Dollar Denominated [Member]

Debt Facilities [Abstract]

Original principal amount

127,500

Balance

$ 121,100

^[1],[2]

$ 125,900

Interest rate

Variable 30 day: 2.447

Interest rate

2.447%

Repayment terms

One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Term

5 years

Current portion of long-term debt

$ 57,100

Credit Agreement Term Loan Facility Japanese Yen Denominated [Member]

Debt Facilities [Abstract]

Original principal amount | ¥

¥ 6.6

Balance

$ 52,300

^[1],[2]

¥ 6.3

^[1],[2]

54,400

¥ 6.5

Interest rate

Variable 30 day: 2.305

Interest rate

2.305%

Repayment terms

One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.

Term

5 years

Current portion of long-term debt

$ 4,100

Credit Agreement Revolving Credit Facility [Member]

Debt Facilities [Abstract]

Original principal amount

Balance

$ 47,500

^[1],[2]

72,500

Interest rate

Variable 30 day: 2.447

Interest rate

2.447%

Repayment terms

Revolving line of credit expires October 2019.

Korea Subsidiary Loan [Member]

Debt Facilities [Abstract]

Original principal amount

$ 20,000

Balance

$ 20,000

^[1],[2]

Interest rate

1.12%

Repayment terms

One half of the principal amount payable on March 17, 2017 and the remainder payable on March 16, 2018.

Unsecured Bonds [Member]

Debt Facilities [Abstract]

Original principal amount | ¥

¥ 2.0

Balance

$ 16,700

¥ 2.0

$ 0

¥ 0.0

Interest rate

0.66%

Repayment terms

Payable in semi-annual installments over three years beginning January 31, 2016.

Term

3 years

Current portion of long-term debt

$ 5,500

Nu Skin Japan Co., Ltd. [Member] | Unsecured Bonds [Member] | Subsequent Event [Member]

Debt Facilities [Abstract]

Original principal amount

$ 0

¥ 0.0

Term

0 years

[1]

As of June 30, 2015, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $71.3 million of the balance of its U.S. dollar denominated debt under the Credit Agreement term loan facility and $3.7 million of the balance of its Japanese yen-denominated debt under the Credit Agreement term loan facility. The Company has classified the amount borrowed under the Credit Agreement revolving credit facility as short term because it is the Company's intention to use this line of credit to borrow and pay back funds over short periods of time.

[2]

The carrying value of the debt reflects the amounts stated in the above table less debt financing costs of $4.9 million, which are not reflected in this table.

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING (Details) $ in Thousands	3 Months Ended			9 Months Ended	12 Months Ended
	Mar. 31, 2015 USD ($) Bs. / $	Jun. 30, 2014 USD ($) Bs. / $	Mar. 31, 2014 USD ($) Bs. / $ Mechanism	Sep. 30, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012	Sep. 30, 2014 USD ($)
Venezuela Highly Inflationary Accounting [Abstract]
Total assets				$ 1,553,458	$ 1,614,434
Monetary assets				$ 305,808	288,415	$ 525,153		$ 194,944
SICAD I [Member] \| Other Income (Expense), Net [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Foreign currency transaction losses on net monetary assets and liabilities		$ (25,300)	$ (14,700)
SIMADI [Member] \| Other Income (Expense), Net [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Foreign currency transaction losses on net monetary assets and liabilities	$ (10,200)
Minimum [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Cumulative inflation rate				100.00%
Venezuela [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Total assets				$ 8,200	14,600
Monetary assets				3,200	$ 8,200
Number of foreign exchange mechanisms \| Mechanism			2
Venezuela [Member] \| SICAD I [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Foreign currency exchange rate \| Bs. / $		50	10.7
Venezuela [Member] \| SIMADI [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Foreign currency exchange rate \| Bs. / $	193
Venezuela [Member] \| Sales Revenue [Member] \| Geographic Concentration Risk [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Concentration percentage					1.00%	1.10%	0.70%
Subsidiary in Venezuela [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Payable to parent company				$ 32,800	$ 34,800
Correct Certain Accounting Errors for Hyper-Inflationary Adjustments with Respect to Operations in Venezuela [Member]
Venezuela Highly Inflationary Accounting [Abstract]
Period used to determine highly inflationary economy				3 years
Out-of-period adjustment to income statement				$ 6,300

LEASE AND FINANCING OBLIGATIONS (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
New Building [Abstract]
Depreciation	$ 52,101	$ 38,933
Lease Agreement for New Regional Headquarters Building [Member]
New Building [Abstract]
Construction-in-progress	20,100
Financing obligation related to lease agreement	10,700
Deposit paid to landlord	9,300
Deferred tenant incentive liability	5,900
Depreciation	$ 200

ADJUSTMENT TO INVENTORY (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
ADJUSTMENT TO INVENTORY (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
ADJUSTMENT TO INVENTORY [Abstract]
Write-down of inventory	$ 37.9	$ 50.0
Total adjustments to inventory carrying value	$ 65.0	$ 56.0

ADDITIONAL QUARTERLY DISCLOSURES (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Inventories [Abstract]
Raw materials	$ 132,808	$ 101,479
Finished goods	127,656	237,012
Inventories	260,464	338,491
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	53,043	86,574
Forward contracts	(83)	1,661
Life insurance contracts	26,713	26,280
Total	79,673	114,515
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	53,043	86,574
Forward contracts	0	0
Life insurance contracts	0	0
Total	53,043	86,574
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Forward contracts	(83)	1,661
Life insurance contracts	0	0
Total	(83)	1,661
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0	0
Forward contracts	0	0
Life insurance contracts	26,713	26,280
Total	26,713	$ 26,280
Life Insurance Contracts [Member]
Changes in Fair Value of Marketable Securities [Roll Forward]
Balance, beginning of period	26,280
Actual Return on Plan Assets [Abstract]
Relating to assets still held at the reporting date	(1,475)
Purchases and issuances	2,282
Sales and settlements	(374)
Transfers into Level 3	0
Balance, end of period	$ 26,713